Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials.
Eur J Clin Pharmacol
; 79(6): 859-871, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37097298
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
Sodium-Glucose Transporter 2 Inhibitors
Type of study:
Clinical_trials
/
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Systematic_reviews
Limits:
Humans
Language:
En
Journal:
Eur J Clin Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Germany